Veri Medtech Holdings, Inc. VRHI
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.10% | 80.30% | -80.82% | 16.11% | -803.24% |
| Total Depreciation and Amortization | 2.78% | 1.41% | -86.16% | 83.21% | 2.19% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.44% | -82.73% | 0.77% | 1.19% | 22.64% |
| Change in Net Operating Assets | 36.77% | -49.05% | 173.38% | 1,268.89% | 102.75% |
| Cash from Operations | -159.43% | 322.78% | -116.44% | 2,006.35% | -109.60% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | 430.51% | -99.02% | 1,361.11% | -45.38% | 12.63% |
| Total Debt Repaid | 70.30% | 86.48% | -264.29% | -17.69% | 8.77% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 107.10% | -147.08% | 75.69% | -83.15% | 23.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -705.19% | 110.69% | -167.61% | 224.56% | -363.89% |